Emricasan
≥99%
- Product Code: 56889
CAS:
254750-02-2
| Molecular Weight: | 569.5 g./mol | Molecular Formula: | C₂₆H₂₇F₄N₃O₇ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Emricasan is primarily used in the field of medical research and treatment, particularly for its potential in addressing liver-related conditions. It functions as a caspase inhibitor, targeting pathways involved in apoptosis (programmed cell death) and inflammation. This makes it a promising candidate for treating liver diseases such as non-alcoholic steatohepatitis (NASH), cirrhosis, and acute-on-chronic liver failure. Additionally, it has been explored for its potential to mitigate liver damage caused by hepatitis viruses and other inflammatory liver disorders. Emricasan is also being studied for its role in reducing injury and improving outcomes in organ transplantation, particularly in preventing ischemia-reperfusion injury. Its anti-inflammatory and anti-apoptotic properties are key to its therapeutic applications.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to off-white Solid |
| PURITY | 99-100 |
| Infrared spectrum | Conforms to Structure |
| LCMS | Consistent with structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿11,680.00 |
+
-
|
| 0.010 | 10-20 days | ฿19,960.00 |
+
-
|
Emricasan
Emricasan is primarily used in the field of medical research and treatment, particularly for its potential in addressing liver-related conditions. It functions as a caspase inhibitor, targeting pathways involved in apoptosis (programmed cell death) and inflammation. This makes it a promising candidate for treating liver diseases such as non-alcoholic steatohepatitis (NASH), cirrhosis, and acute-on-chronic liver failure. Additionally, it has been explored for its potential to mitigate liver damage caused by hepatitis viruses and other inflammatory liver disorders. Emricasan is also being studied for its role in reducing injury and improving outcomes in organ transplantation, particularly in preventing ischemia-reperfusion injury. Its anti-inflammatory and anti-apoptotic properties are key to its therapeutic applications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :